Author

Alejandro Chaves-Martinez

University of California, San Francisco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Axel Hyrenius WittsteniD· 1 shared Brian Rudolph ShyiD· 1 shared Chloë Thienpont· 1 shared Claire E. Hilburger· 1 shared Greg M. AlleniD· 1 shared Iowis ZhuiD· 1 shared Julie M. GarciaiD· 1 shared Kole T. RoybaliD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Axel Hyrenius WittstenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Synthetic Hybrid Receptors for Safer and Programmable T Cell Therapy

Maxwell Gabriel Foisey, Julie M. Garcia, Xun Li, Xiaoyu Yang, Claire E. Hilburger, Chloë Thienpont, Alejandro Chaves-Martinez, Serkan Belkaya, Tina Truong, Iowis Zhu, Raymond Liu, Axel Hyrenius Wittsten, Ricardo Almeida, Brian Rudolph Shy, Greg M. Allen, , Kole T. Roybal

This paper introduces Hybrid Receptors (Hybrid-Rs) to improve T cell therapy safety and programmability by combining CAR and SNIPR features for controlled gene regulation and reduced toxicity.

bioRxiv · Jan 23, 2026 · PreprintBioengineering